JDRF News Blog - TypeOneNation

| |

JDRF News Blog

Thirty Years Wiser: How the DCCT trial continues to nurture the landscape of type 1 diabetes science

Posted 1 month ago

by Tara Wilcox-Ghanoonparvar
- 0 Comments
In 1983, a trial began that would forever alter the standard of management of type 1 diabetes (T1D) and serve as a stepping stone to future research advances—and as we mark the 30th anniversary of the trial’s inception, we are still learning...
JDRF News Blog

JDRF Convenes Forum on the Psychosocial Burdens of Type 1 Diabetes

Posted 2 months ago

by Gary Feit
- 1 Comments
JDRF recently brought together a group of 20 leading experts in the behavioral and mental health fields to discuss the range of psychological and social issues experienced by people with type 1 diabetes (T1D) and their families. Forums like this enable...
JDRF News Blog

Pediatric Diabetes Registry Reveals T1D Increase

Posted 3 months ago

by Shana
- 0 Comments
In order to prevent and ultimately achieve a world without type 1 diabetes (T1D), we must first learn more about the disease. One trend that has revealed itself in recent years is an accelerating rate of T1D, especially among younger children. Last year...
JDRF News Blog

An Artificial Pancreas System in Action

Posted 3 months ago

by Liz Cuebas
- 1 Comments
When JDRF started the Artificial Pancreas Project in 2006, the project was long on theoretical concepts but short on hard data. Scientists believed there should be a way to improve daily T1D management by connecting the reading from a continuous glucose...
JDRF News Blog

People with T1D Inspiring Others

Posted 4 months ago

by Andrew Bell
- 0 Comments
Living with type 1 diabetes (T1D), to say the least, is no cake walk. Let’s be honest, it’s downright tiring and absolutely challenging sometimes. Despite this truth, and in the face of nearly impossible obstacles, people with T1D still do...
JDRF News Blog

JDRF Completes First Stage of the Glucose Responsive Insulin Grand Challenge

Posted 5 months ago

by Michael
- 1 Comments
In September, JDRF wrapped up the first stage of its first-ever crowdsourcing challenge to garner ideas for developing a glucose responsive insulin (GRI) drug. The Agnes Varis GRI Grand Challenge Prize, the first stage of which was called the “Theoretical...
JDRF News Blog

Eggnog Etiquette

Posted 5 months ago

by William Sorensen
- 2 Comments
During the holidays , you eat and drink with everyone from your second cousin’s hair stylist to the soccer coach for your college roommate’s kid. If you have T1D, as I do, be ready for well-meaning people to ask you some of the same questions...
JDRF News Blog

Nanoparticle Research Shows Promise for T1D and Other Autoimmune Diseases

Posted 5 months ago

by Gary Feit
- 0 Comments
One of the toughest challenges in halting or reversing the autoimmune process that destroys beta cells and causes type 1 diabetes is doing so in a way that does not compromise a person’s entire immune system. Antigen-specific immune therapy research...
JDRF News Blog

Implanted Encapsulated Pancreatic Islet Product Safely Demonstrates Improvement of T1D Management

Posted 6 months ago

by Tara Wilcox-Ghanoonparvar
- 0 Comments
In September, Living Cell Technologies (LCT) revealed positive results from its JDRF-funded Phase II study of DIABECELL—a unique proprietary encapsulation technology comprised of encapsulated pancreatic islets from pigs. According to LCT’s...
JDRF News Blog

JDRF Discusses New Treatment for Diabetic Eye Disease

Posted 7 months ago

by Liz Cuebas
- 1 Comments
Eye disease is one of the most common complications of type 1 diabetes. Eye disease in people with diabetes, also known as diabetic retinopathy , is caused by chronic high blood sugar levels, which can damage the blood vessels in the retina of the eye...
JDRF News Blog

Recap of Recent JDRF Cure Research Studies

Posted 7 months ago

by Shana
- 0 Comments
In our efforts to cure T1D, JDRF actively supports research aimed at restoring a person's insulin-producing capability and halting or reversing the body's misguided immune attack on the pancreas. A cure for T1D remains JDRF’s key priority...
JDRF News Blog

JDRF collaborates to fill gaps in encapsulation research for type 1 diabetes

Posted 8 months ago

by Michael
- 1 Comments
Recently, JDRF announced that it is jointly funding research at the Diabetes Research Institute (DRI) with The Leona M. and Harry B. Helmsley Charitable Trust . The grant will support the efforts of Dr. Camillo Ricordi and his team as they work to advance...
JDRF News Blog

JDRF Science Workshop Attempts to Unravel a Fundamental T1D Disease Mechanism

Posted 9 months ago

by Gary Feit
- 0 Comments
JDRF scientists and their colleagues recently published the key insights from a JDRF-organized workshop with leading experts who met to discuss a potential basic disease mechanism in T1D. JDRF’s unique network of scientific collaborators enables...
JDRF News Blog

T1D Rise Among Youth Highlights the Importance of Renewed Research Funding

Posted 9 months ago

by Tara Wilcox-Ghanoonparvar
- 1 Comments
In June, the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH) released results from their latest SEARCH for Diabetes in Youth study . The data revealed a 23 percent growth in type 1 diabetes (T1D) prevalence...
JDRF News Blog

True Descriptions

Posted 10 months ago

by William Sorensen
- 0 Comments
In the newly released True Believers , author Kurt Andersen’s narrator and lead character is a celebrated 64-year-old attorney named Karen Hollander. She also has T1D. Her diagnosis follows a memorable night when everything is perfect: She’s...
JDRF News Blog

JDRF Joins the T1D Community at Children with Diabetes Friends For Life

Posted 10 months ago

by Andrew Bell
- 0 Comments
Last week, JDRF staff and volunteers had the opportunity to join the T1D community at another successful Children with Diabetes (CWD) Friends For Life (FFL) conference in Orlando, Florida. This year’s event, the 13 th annual meeting, like the previous...
JDRF News Blog

JDRF: A Strong Presence at the ADA 72nd Scientific Sessions

Posted 10 months ago

by Liz Cuebas
- 0 Comments
Earlier this month, JDRF participated in the American Diabetes Association’s 72 nd Scientific Sessions (held June 8 th through 12 th in Philadelphia). This conference, held annually, brings together over 13,000 members of the international diabetes...
JDRF News Blog

Inside The Pitch

Posted 11 months ago

by Scott McCormick
- 2 Comments
I have to admit, when I was first approached by our LA Chapter about possible participation in AMC's new unscripted series, The Pitch , I hesitated. As one ad agency remarked, on why they didn't participate, "We don't want to be mentioned...
JDRF News Blog

Getting it Right: Recent Portrayal of T1D in Mass Media

Posted 11 months ago

by Shana
- 1 Comments
Although diabetes is one of the most common diseases in the U.S., our mass media and popular culture don’t always portray it accurately. Some of the most common misunderstandings result from confusion between type 1 diabetes (T1D) and type 2 diabetes...
JDRF News Blog

New Study Discovers Cause of Pain in Diabetic Neuropathy

Posted over 1 year ago

by Gary Feit
- 0 Comments
Diabetic neuropathy , or nerve damage, is one of the most painful complications faced by people with diabetes. Over time, high blood sugar associated with diabetes may lead to nerve damage. In the legs and feet, this nerve damage frequently results in...
JDRF News Blog

JDRF Uses Clinical Trials Connection to Play Matchmaker

Posted over 1 year ago

by Michael
- 1 Comments
Recently, the Wall Street Journal published an article about matching patients with their ideal clinical trials, which focused on the growing trend of patient advocacy groups and their efforts to encourage clinical trial participation. In addition to...
JDRF News Blog

T1D reversed in mice using engineered gut bacteria

Posted over 1 year ago

by Tara Wilcox-Ghanoonparvar
- 1 Comments
An oral treatment of harmless, specially engineered gut bacteria was able to reverse type 1 diabetes (T1D) in experimental mice, according to a partially JDRF-funded study in Belgium. The findings , which were recently published in the April edition of...
JDRF News Blog

New Industry Partnership Paves the Way for Drug Development for Beta Cell Regeneration

Posted over 1 year ago

by Liz Cuebas
- 1 Comments
JDRF industry partner NGM Biopharmaceuticals, Inc., recently announced a new partnership with Daiichi Sankyo Company, Ltd., a Japanese pharmaceutical company. The partnership will focus on discovering and developing drugs to regenerate pancreatic beta...
JDRF News Blog

MRI Scanning Technique Predicts T1D Onset

Posted over 1 year ago

by Shana
- 0 Comments
In a recent study published in the current issue of Nature Immunology , a JDRF-funded team led by Dr. Diane Mathis from the Harvard Medical School and Massachusetts General Hospital developed a technique that uses MRI and nanoparticles for predicting...
JDRF News Blog

Novel technology may help new beta cells survive

Posted over 1 year ago

by Gary Feit
- 2 Comments
Replacing the body’s insulin-producing beta cells is one potential method for curing type 1 diabetes (T1D). Researchers are attempting to solve a number of challenges to make beta cell replacement a reality. These include: overcoming the misguided...